PATENT CLAIM ANALYSIS

Application Number: 15949703
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "225200"]

Abstract:
The subject invention concerns materials and methods for treating depression, stress disorders, such as PTSD, anxiety disorders, and/or a neurodegenerative disease or condition in a person or animal. In one embodiment, a person or animal in need of treatment is administered one or more compounds or drugs, or a composition comprising the one or more compounds or drugs, that inhibit FKBP51 activity or function. The subject invention also concerns a method for inhibiting activity of the FKBP51 protein in a cell. The subject invention also concerns methods of screening for compounds or drugs that inhibit the FKBP51 protein.

Claim (Index 15):
The method according to  claim 13 , wherein said cell is contacted in an in vivo environment.

Metadata:
- Claim Count in Document: 27.0
- Percentile: 91.0
- Lexical Diversity: 2.09615
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15209594', '14788364', '12994560', '15467867', '15655683']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7372994196295695
- 35 USC 102 Novelty (BERT): 0.5452225041511014
- Combined Prediction Score: 0.7180917280817227
- Mean Citation Score: 238.789368
- Max Citation Score: 377.39816
- Similarity Product: 177.78171287598133

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test